aminocaproic acid has been researched along with Aging in 6 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The therapeutic plasma concentration of EACA has been scientifically determined for the adult population, but the current recommended dosage for neonates has been empirically derived from adult studies." | 1.36 | The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro. ( Eaton, MP; Liu, X; Tu, X; Wissler, RN; Yurka, HG; Zanghi, CN, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leroux, P | 1 |
| Omouendze, PL | 1 |
| Roy, V | 1 |
| Dourmap, N | 1 |
| Gonzalez, BJ | 1 |
| Brasse-Lagnel, C | 1 |
| Carmeliet, P | 1 |
| Leroux-Nicollet, I | 1 |
| Marret, S | 1 |
| Yurka, HG | 1 |
| Wissler, RN | 1 |
| Zanghi, CN | 1 |
| Liu, X | 1 |
| Tu, X | 1 |
| Eaton, MP | 1 |
| Pashley, DH | 1 |
| Tay, FR | 1 |
| Yiu, C | 1 |
| Hashimoto, M | 1 |
| Breschi, L | 1 |
| Carvalho, RM | 1 |
| Ito, S | 1 |
| Foster, JA | 1 |
| Rich, CB | 1 |
| DeSa, MD | 1 |
| Jackson, AS | 1 |
| Fletcher, S | 1 |
| Ries, M | 1 |
| Zenker, M | 1 |
| Gaffney, PJ | 1 |
| MacIomhair, M | 1 |
| Lavelle, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Influence of the Number of Layers of a One Bottle Adhesive on the Longevity of Composite Resin Restorations in Primary Molars - Randomized Controlled Clinical Study.[NCT01680289] | 60 participants (Anticipated) | Interventional | 2012-08-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for aminocaproic acid and Aging
| Article | Year |
|---|---|
Collagen degradation by host-derived enzymes during aging.
Topics: Acid Etching, Dental; Aging; Aminocaproic Acid; Anti-Infective Agents, Local; Benzamidines; Chlorhex | 2004 |
5 other studies available for aminocaproic acid and Aging
| Article | Year |
|---|---|
Age-dependent neonatal intracerebral hemorrhage in plasminogen activator inhibitor 1 knockout mice.
Topics: Age Factors; Aging; Aminocaproic Acid; Animals; Animals, Newborn; Aprotinin; Cerebral Hemorrhage; Di | 2014 |
The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro.
Topics: Adult; Aging; Aminocaproic Acid; Antifibrinolytic Agents; Cesarean Section; Dose-Response Relationsh | 2010 |
Improved methodologies for the isolation and purification of tropoelastin.
Topics: Aging; Amino Acids; Aminoacetonitrile; Aminocaproates; Aminocaproic Acid; Animals; Chickens; Chromat | 1980 |
Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
Topics: Adult; Aging; Aminocaproic Acid; Dose-Response Relationship, Drug; Fetal Blood; Fibrin; Fibrinolysis | 2000 |
Thrombus weight as a measure of hypercoagulability induced by drugs.
Topics: Adenosine Diphosphate; Aging; Aminocaproates; Aminocaproic Acid; Animals; Benzopyrans; Blood Coagula | 1979 |